JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201524200 on April 8, 2002

J. Biol. Chem., Vol. 277, Issue 27, 24744-24752, July 5, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/27/24744    most recent
M201524200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simm, A. M.
Right arrow Articles by Walsh, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simm, A. M.
Right arrow Articles by Walsh, T. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characterization of Monomeric L1 Metallo-beta -lactamase and the Role of the N-terminal Extension in Negative Cooperativity and Antibiotic Hydrolysis*

Alan M. SimmDagger §, Catherine S. HigginsDagger , Anne L. Carenbauer, Michael W. Crowder, John H. Bateson||, Peter M. BennettDagger , Anthony R. Clarke**, Stephen E. Halford**, and Timothy R. WalshDagger

From the Dagger  Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, United Kingdom, the  Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio 45056, the || Department of Medicinal Chemistry, GlaxoSmithKline Pharmaceuticals, Harlow, Essex CM19 5AW, United Kingdom, and the ** Department of Biochemistry, University of Bristol, Bristol BS8 1TD, United Kingdom

The L1 metallo-beta -lactamase from Stenotrophomonas maltophilia is unique among this class of enzymes because it is tetrameric. Previous work predicted that the two regions of important intersubunit interaction were the residue Met-140 and the N-terminal extensions of each subunit. The N-terminal extension was also implicated in beta -lactam binding. Mutation of methionine 140 to aspartic acid results in a monomeric L1 beta -lactamase with a greatly altered substrate specificity profile. A 20-amino acid N-terminal deletion mutant enzyme (N-Del) could be isolated in a tetrameric form but demonstrated greatly reduced rates of beta -lactam hydrolysis and different substrate profiles compared with that of the parent enzyme. Specific site-directed mutations of individual N terminus residues were made (Y11S, W17S, and a double mutant L5A/L8A). All N-terminal mutant enzymes were tetramers and all showed higher Km values for ampicillin and nitrocefin, hydrolyzed ceftazidime poorly, and hydrolyzed imipenem more efficiently than ampicillin in contrast to wild-type L1. Nitrocefin turnover was significantly increased, probably because of an increased rate of breakdown of the intermediate species due to a lack of stabilizing forces. Km values for monomeric L1 were greatly increased for all antibiotics tested. A model of a highly mobile N-terminal extension in the monomeric enzyme is proposed to explain these findings. Tetrameric L1 shows negative cooperativity, which is not present in either the monomer or N-terminal deletion enzymes, suggesting that the cooperative effect is mediated via N-terminal intersubunit interactions. These data indicate that while the N terminus of L1 is not essential for beta -lactam hydrolysis, it is clearly important to its activity and substrate specificity.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Pathology and Microbiology, School of Medical Sciences, University Walk, University of Bristol, Bristol, BS8 1TD UK. Tel.: 44-(0)117-928-7897; Fax: 44- (0)117-928-7896; E-mail: A.M.Simm@bristol.ac.uk.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. S. Mercuri, I. Garcia-Saez, K. De Vriendt, I. Thamm, B. Devreese, J. Van Beeumen, O. Dideberg, G. M. Rossolini, J.-M. Frere, and M. Galleni
Probing the Specificity of the Subclass B3 FEZ-1 Metallo-{beta}-lactamase by Site-directed Mutagenesis
J. Biol. Chem., August 6, 2004; 279(32): 33630 - 33638.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
G. Periyannan, P. J. Shaw, T. Sigdel, and M. W. Crowder
In vivo folding of recombinant metallo-{beta}-lactamase L1 requires the presence of Zn(II)
Protein Sci., August 1, 2004; 13(8): 2236 - 2243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.